The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...
Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. View on euronews ...
A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.
The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...
For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results